Skip to content GentiBio
  • About
  • Our Team
  • Scientific Approach
    • Our Engineering
    • Our Platform
    • Publications
  • Pipeline & Programs
    • Our Pipeline
    • GNTI-122
  • Careers
  • News
  • Contact
GentiBio Mobile Menu Toggle navigation
GentiBio
  • About
  • Our Team
  • Scientific Approach
    • Our Engineering
    • Our Platform
    • Publications
  • Pipeline & Programs
    • Our Pipeline
    • GNTI-122
  • Careers
  • News
  • Contact

Publications

  • May 18, 2022

    Generation of Islet-specific Engineered Regulatory T Cells (EngTregs) for Immune Tolerance Induction in Type 1 Diabetes Using a Novel Dual-editing Strategy

    Cook et al. (2022) ASGCT, Presidential Symposium abstract 810

  • June 03, 2020

    Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function

    Honaker et al.  (2020)  Sci. Transl. Med. 12, eaay6422

GentiBio

© 2023 GentiBio

  • Contact
  • Terms and Conditions
  • Privacy Policy
  • Site Credits
  • Twitter
  • LinkedIn